Schwannomas

3 registered clinical trials studyying Schwannomas — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342	Reveal Pharmaceuticals Inc.	Phase 2
Recruiting	Screening Trial for Pain Relief in Schwannomatosis (STARFISH) NCT05684692	Massachusetts General Hospital	Phase 2
Completed	Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET NCT03542773	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1